Teleflex
About: Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Employees: 14,100
0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
2.35% more ownership
Funds ownership: 99.12% [Q4 2024] → 101.47% (+2.35%) [Q1 2025]
2% more repeat investments, than reductions
Existing positions increased: 153 | Existing positions reduced: 150
0% more funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 2 (+0) [Q1 2025]
18% less funds holding
Funds holding: 507 [Q4 2024] → 417 (-90) [Q1 2025]
21% less capital invested
Capital invested by funds: $8.19B [Q4 2024] → $6.5B (-$1.69B) [Q1 2025]
52% less first-time investments, than exits
New positions opened: 79 | Existing positions closed: 164
66% less call options, than puts
Call options by funds: $2.87M | Put options by funds: $8.55M
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$137
18%
upside
Avg. target
$148
27%
upside
High target
$173
49%
upside
4 analyst ratings
1 positive
25%
3 neutral
75%
0 negative
0%
Truist Securities Richard Newitter | 18%upside $137 | Hold Maintained | 5 May 2025 |
Morgan Stanley Patrick Wood | 49%upside $173 | Overweight Maintained | 5 May 2025 |
RBC Capital Shagun Singh | 25%upside $145 | Sector Perform Maintained | 2 May 2025 |
Wells Fargo Larry Biegelsen | 18%upside $137 | Equal-Weight Maintained | 2 May 2025 |
Financial journalist opinion
Based on 3 articles about TFX published over the past 30 days
Positive
Zacks Investment Research
1 week ago
Teleflex Acquires BIOTRONIK's Vascular Intervention Business, Stock Up
TFX gains 2.9% after acquiring BIOTRONIK's vascular unit, boosting its cath lab presence and innovation pipeline.
Neutral
GlobeNewsWire
1 week ago
Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business
WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG. The acquisition adds a broad portfolio of therapeutic products to Teleflex's portfolio of interventional access products, driving an enhanced global presence in the cath lab. The Vascular Intervention business will also establish Teleflex's global footprint in the fast-growing peripheral intervention market, and provide a channel for Teleflex products that currently have a peripheral indication.
Neutral
GlobeNewsWire
4 weeks ago
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters (CVCs). This prospective cohort study included more than 6,670 patients from 12 Intensive care units in eight hospitals across India, Malaysia, Papua New Guinea, Colombia, Egypt and Turkey.
Neutral
GlobeNewsWire
1 month ago
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month
Timed with National Men's Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men 1 —and encourages them to take control of their health.
Neutral
GlobeNewsWire
1 month ago
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: TFX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public.
Neutral
Accesswire
1 month ago
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX
NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / WHY: New York, N.Y., May 21, 2025.
Neutral
PRNewsWire
1 month ago
Teleflex Investor News: Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX
NEW YORK , May 20, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public. So What: If you purchased Teleflex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Neutral
GlobeNewsWire
1 month ago
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: TFX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public.
Neutral
GlobeNewsWire
1 month ago
Teleflex Publishes 2024 Global Impact Report
Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program
Neutral
Accesswire
1 month ago
Lost Money on Teleflex Incorporated (TFX)? Possible Fraud - Contact Levi & Korsinsky Today
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Teleflex Incorporated ("Teleflex Incorporated") (NYSE:TFX) concerning possible violations of federal securities laws. On February 27, 2025, Fierce Biotech published an article entitled "Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal.
Charts implemented using Lightweight Charts™